Christina Hughes
About Christina Hughes
Christina Hughes is the Director of WW Medical Affairs, Hematology Myeloid at Bristol Myers Squibb, with extensive experience in medical and scientific affairs.
Current Role at Bristol Myers Squibb
Christina Hughes currently holds the position of Director in Worldwide Medical Affairs for Hematology Myeloid at Bristol Myers Squibb. Based in Summit, New Jersey, she has been with the company since November 2020. In this role, she provides leadership and strategic direction in medical affairs, focusing on hematological malignancies within the myeloid lineage.
Previous Experience at Envision Communications
Before joining Bristol Myers Squibb, Christina Hughes worked at Envision Communications as Vice President of Scientific Strategy. She held this position from 2018 to 2020, for a duration of two years. Her role likely involved strategic planning and implementation of scientific communications within the company.
Roles at Medical Exchange International
Christina Hughes had an extensive tenure at Medical Exchange International, holding several senior positions. She served as Vice President of Medical and Scientific Affairs from 2017 to 2018, Senior Director of Medical and Scientific Affairs in 2016 for seven months, and Director of Medical and Scientific Affairs from 2015 to 2016 for eleven months. These roles were based in New York, NY and involved significant responsibilities in medical and scientific affairs.
Education and Academic Background
Christina Hughes has a robust academic background in the field of life sciences. She completed her Ph.D. in Virology from Harvard University from 1999 to 2006. Prior to that, she earned her A.B. in Biological Sciences from Cornell University, where she studied from 1995 to 1999. This strong educational foundation has provided her with in-depth knowledge and expertise in biological and medical sciences.
Work at The Rockefeller University
Christina Hughes spent six years working as a Postdoctoral Associate at The Rockefeller University from 2006 to 2012. During this period, she contributed to advanced research projects, further refining her expertise in scientific research and medical sciences.